Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 21, Issue 3, 2008, Pages 281-290

  Kaipel, Martin ^a   Wagner, Andreas ^c   Wassermann, Esther ^b   Vorauer Uhl, Karola ^d   Kellner, Richard ^b   Redl, Heinz ^b   Katinger, Hermann ^d   Ullrich, Roman ^e  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG GMBH   (Austria)

^d UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COPPER ZINC SUPEROXIDE DISMUTASE; DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOSOME; PHOSPHATIDYLGLYCEROL;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG HALF LIFE; ENCAPSULATION; FEMALE; LEUKOCYTE; LUNG; LUNG LAVAGE; MALE; NONHUMAN; PH; RESPIRATORY SYSTEM; SWINE; SYSTEMIC CIRCULATION;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE FLUID; DELAYED-ACTION PREPARATIONS; FEMALE; FREE RADICAL SCAVENGERS; HALF-LIFE; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; RECOMBINANT PROTEINS; SUPEROXIDE DISMUTASE; SWINE;

EID: 54949087525     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2007.0667     Document Type: Article

References (23)

1. Bergamini CM, Gambetti S, Dondi A, and Cervellati C: Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des. 2004;10:1611-1626.
2. Cuzzocrea S, Riley DP, Caputi AP, and Salvemini D: Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53:135-159.
3. Kiziltunc A, Cogalgil S, and Cerrahoglu L: Carnitine and antioxidants levels in patients with rheumatoid arthritis. Scand J Rheumatol. 1998:27:441-445.
4. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, and Durak I: Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int. 1999;19:35-37.
5. O'Dell JR: Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350:2591-2602.
6. Goebel KM, Storck U, and Neurath F: Intrasynovial orgotein therapy in rheumatoid arthritis. Lancet. 1981;1:1015-1017.
7. Simoes SI, Delgado TC, Lopes RM, Jesus S, Ferreira AA, Morais JA, Cruz ME, Corvo ML, and Martins MB: Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in Transfersomes. J Control Release. 2005;103:419-434.
8. Wang JH, Chen HS, Wang T, Diao YF, and Tian KL: Oxygen-derived free radicals induced cellular injury in superior mesenteric artery occlusion shock: protective effect of superoxide dismutase. Circ Shock. 1990;32:31-41.
9. Morpurgo E, Cadrobbi R, Morpurgo M, Rigotti P, Schiavon F, Schiavon O, Caliceti P, Ancona E, and Veronese FM: Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury. Transplantation. 1996;62:1221-1223.
10. Uematsu T, Nagashima S, Umemura K, Kanamaru M, and Nakashima M: Pharmacokinetics and safety of intravenous recombinant human superoxide dismutase (NK341) in healthy subjects. Int J Clin Pharmacol Ther. 1994;32:638-641.
11. Luisa Corvo M, Jorge JC, van't Hof R, Cruz ME, Crommelin DJ, and Storm G: Superoxide dismutase entrapped in long-circulating liposomes: formulation design and therapeutic activity in rat adjuvant arthritis. Biochim Biophys Acta. 2002;1564:227-236.
12. Fichtner I, Arndt D, Reszka R, and Gens J: Pharmacokinetic behavior of [57Co]bleomycin liposomes in mice: comparison with the unencapsulated substance. Anticancer Drugs. 1991;2:555-563.
13. Davis JM, Rosenfeld WN, Richter SE, Parad MR, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Tierney J, and Horowitz S: Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics. 1997;100:24-30.
14. Bayer JA, De Vries P, Herweijer H, and Bauman JG: The use of E. coli exonuclease III to generate single stranded DNA in BrdUrd cell-cycle analysis permits simultaneous detection of cell surface antigens. J Immunol Methods. 1990;132:13-24.
15. Wagner A, Vorauer-Uhl K, Kreismayr G, and Katinger H: The crossflow injection technique: an improvement of the ethanol injection method. J Liposome Res. 2002;12:259-270.
16. Wagner A, Vorauer-Uhl K, Kreismayr G, and Katinger H: Enhanced protein loading into liposomes by the multiple crossflow injection technique. J Liposome Res. 2002;12:271-283.
17. Wagner A, Vorauer-Uhl K, and Katinger H: Liposomes produced in a pilot scale: production, purification and efficiency aspects. Eur J Pharm Biopharm. 2002;54:213-219.
18. Wagner A, Vorauer-Uhl K, and Katinger H: Nebulization of liposomal rh-Cu/Zn-SOD with a novel vibrating membrane nebulizer. J Liposome Res. 2006;16:113-125.
19. Braun E, Wagner A, Fürnschlief E, Katinger H, and Vorauer-Uhl K: Experimental design for in vitro skin penetration study of liposomal superoxide dismutase. J Pharm Biomed Anal. 2006;40:1187-1197.
20. Kinnula VL, and Crapo JD: Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med. 2003;167:1600-1619.
21. Labiris NR, and Dolovich MB: Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol. 2003;56:588-599.
22. Liu FY, Shao Z, Kildsig DO, and Mitra AK: Pulmonary delivery of free and liposomal insulin. Pharm Res. 1993;10:228-232.
23. Agu RU, Ugwoke MI, Armand M, Kinget R, and Verbeke N: The lung as a route for systemic delivery of therapeutic proteins and peptides. Respir Res. 2001;2:198-209.